Tenderwize
Back to tender search

Open-house biologics rebate agreement for Epoetin beta

Techniker Krankenkasse·Hamburg, Germany·Deadline Jan 30, 2028 · 530 days left·Open·Supplies
Original notice title

Germany – Pharmaceutical products – Open-House-Biologika-Rabattverträge 2025-39 - Epoetin beta

52/100

Opportunity Score

Needs reviewMedium complexity
SuppliesOpen
Why this score?

Opportunity

52 / 100

Complexity

58 / 100

Risk factors

The notice contains two different end-time references: structured data gives 2028-01-30 22:59:59 UTC, while the XML not...

Participation is limited to pharmaceutical undertakings meeting the AMG and authorisation conditions for the specific p...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until Jan 2028
  • Supply-related pharmaceutical rebate agreement for Epoetin beta.
  • Open-house arrangement with uniform contractual conditions for all eligible participants.
Show full summary

Open-house pharmaceutical supply arrangement for Epoetin beta in Germany, led by Techniker Krankenkasse with HEK and hkk as participating buyers. The notice states that any suitable pharmaceutical undertaking may join during the contract period, subject to the stated legal and self-declaration requirements. No contract value is provided. Submission is not via the portal; contracts must be sent by email with qualified electronic signature or by post, and the documents are only available electronically. The notice is in German and the extracted TED XML notice was analyzed, but no separate procurement document text was provided.

Risks

The notice contains two different end-time references: structured data gives 2028-01-30 22:59:59 UTC, while the XML not...

Participation is limited to pharmaceutical undertakings meeting the AMG and authorisation conditions for the specific p...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Applicant must be a pharmaceutical undertaking within the meaning of Section 4(18) AMG for the offered medicinal product(s).
  • Applicant must have its seat in the AMG territory, another EU Member State, or another EEA state.
  • Applicant must hold a valid marketing authorisation for the relevant medicinal product(s), or otherwise be entitled to place them on the market in its own name.

Buyer

Location

Hamburg, DEU

Identifier

992-80116-93

Activity

Health

Lots (1)

LOT-0001

Open-house biologics rebate agreement for Epoetin beta

Open-house contract for pharmaceutical rebate agreements under Section 130c(1) SGB V for the active substance Epoetin beta. The lot covers nationwide performance in Germany and is described as an open-house procedure with uniform conditions, no individual negotiations, and no exclusivity. The lot information comes from structured data and the TED XML notice.

SuppliesEU fundedElectronic submission

Location

DE600, Germany

Duration

Jan 2026 - Jan 2028

Category

Pharmaceutical products

Deadline

Deadline Jan 30, 2028

Procurement Details

Publication date
03 Dec 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
803675-2025

Documents (1)

Similar tenders